MJB
DXCM icon

Mark J. Bradley’s DexCom DXCM Stock Holding History

Mark J. Bradley’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$4.02M Sell
31,278
-17,955
-36% -$2.17M 3.99% 6
2023
Q1 		$5.72M Buy
49,233
+5,803
+13% +$650K 4.15% 5
2022
Q4 		$4.92M Sell
43,430
-147
-0.3% -$16.1K 4.37% 5
2022
Q3 		$3.51M Buy
43,577
+1,225
+3% +$104K 3.25% 8
2022
Q2 		$3.16M Sell
42,352
-620
-1% -$56.6K 2.86% 10
2022
Q1 		$5.5M Sell
42,972
-640
-1% -$70K 3.92% 2
2021
Q4 		$5.86M Sell
43,612
-5,040
-10% -$724K 3.83% 3
2021
Q3 		$6.65M Sell
48,652
-2,520
-5% -$318K 4.55% 2
2021
Q2 		$5.46M Sell
51,172
-3,700
-7% -$355K 3.65% 4
2021
Q1 		$4.93M Sell
54,872
-1,180
-2% -$111K 3.34% 6
2020
Q4 		$5.18M Buy
+56,052
New +$5M 3.57% 6

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mark J. Bradley's DXCM Position: Q2 2023 in Review

Mark J. Bradley reduced its DexCom (DXCM) stake by 36% in Q2 2023, selling an estimated $2.17M and leaving 31,278 shares worth $4.02M. The position accounts for 3.99% of the portfolio, ranked #6.

Mark J. Bradley first reported a position in DXCM in Q4 2020 and has held it in 11 quarters since. The position peaked at $6.65M in Q3 2021. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • Mark J. Bradley held 31,278 shares of DexCom worth $4.02M as of Q2 2023.
  • Mark J. Bradley sold 17,955 DexCom shares in Q2 2023, an estimated $2.17M.
  • DexCom made up 3.99% of Mark J. Bradley's portfolio in Q2 2023, its #6 holding.
  • Mark J. Bradley first reported a position in DexCom in Q4 2020 and has held it in 11 quarters since.
  • Mark J. Bradley's DexCom position peaked at $6.65M in Q3 2021.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Mark J. Bradley's 13F filing for Q2 2023, filed 7 Aug 2023.